Pastan I - Search Results

1

Anti-mesothelin immunotoxin induces mesothelioma eradication, anti-tumor immunity, and the development of tertiary lymphoid structures.

Liu W, Tai CH, Liu X, Pastan I. Liu W, et al. Among authors: pastan i. Proc Natl Acad Sci U S A. 2022 Nov 29;119(48):e2214928119. doi: 10.1073/pnas.2214928119. Epub 2022 Nov 21. Proc Natl Acad Sci U S A. 2022. PMID: 36409889 Free PMC article.

2

Intrathecal administration of single-chain immunotoxin, LMB-7 [B3(Fv)-PE38], produces cures of carcinomatous meningitis in a rat model.

Pastan IH, Archer GE, McLendon RE, Friedman HS, Fuchs HE, Wang QC, Pai LH, Herndon J, Bigner DD. Pastan IH, et al. Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2765-9. doi: 10.1073/pnas.92.7.2765. Proc Natl Acad Sci U S A. 1995. PMID: 7708720 Free PMC article.

3

Mesothelin: a new target for immunotherapy.

Hassan R, Bera T, Pastan I. Hassan R, et al. Among authors: pastan i. Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):3937-42. doi: 10.1158/1078-0432.CCR-03-0801. Clin Cancer Res. 2004. PMID: 15217923 Review.

4

Cell membrane-specific epitopes on CD30: Potentially superior targets for immunotherapy.

Nagata S, Ise T, Onda M, Nakamura K, Ho M, Raubitschek A, Pastan IH. Nagata S, et al. Proc Natl Acad Sci U S A. 2005 May 31;102(22):7946-51. doi: 10.1073/pnas.0502975102. Epub 2005 May 19. Proc Natl Acad Sci U S A. 2005. PMID: 15905329 Free PMC article.

5

Localization of mesothelin in epithelial ovarian cancer.

Hassan R, Kreitman RJ, Pastan I, Willingham MC. Hassan R, et al. Among authors: pastan i. Appl Immunohistochem Mol Morphol. 2005 Sep;13(3):243-7. doi: 10.1097/01.pai.00000141545.36485.d6. Appl Immunohistochem Mol Morphol. 2005. PMID: 16082249

6

Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer.

Hassan R, Remaley AT, Sampson ML, Zhang J, Cox DD, Pingpank J, Alexander R, Willingham M, Pastan I, Onda M. Hassan R, et al. Among authors: pastan i. Clin Cancer Res. 2006 Jan 15;12(2):447-53. doi: 10.1158/1078-0432.CCR-05-1477. Clin Cancer Res. 2006. PMID: 16428485

7

Isolation of anti-CD22 Fv with high affinity by Fv display on human cells.

Ho M, Nagata S, Pastan I. Ho M, et al. Among authors: pastan i. Proc Natl Acad Sci U S A. 2006 Jun 20;103(25):9637-42. doi: 10.1073/pnas.0603653103. Epub 2006 Jun 8. Proc Natl Acad Sci U S A. 2006. PMID: 16763048 Free PMC article.

8

Megakaryocyte potentiation factor cleaved from mesothelin precursor is a useful tumor marker in the serum of patients with mesothelioma.

Onda M, Nagata S, Ho M, Bera TK, Hassan R, Alexander RH, Pastan I. Onda M, et al. Among authors: pastan i. Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4225-31. doi: 10.1158/1078-0432.CCR-06-0472. Clin Cancer Res. 2006. PMID: 16857795

9

Immunotoxin treatment of cancer.

Pastan I, Hassan R, FitzGerald DJ, Kreitman RJ. Pastan I, et al. Annu Rev Med. 2007;58:221-37. doi: 10.1146/annurev.med.58.070605.115320. Annu Rev Med. 2007. PMID: 17059365 Review.

10

Evolution and expression of chimeric POTE-actin genes in the human genome.

Lee Y, Ise T, Ha D, Saint Fleur A, Hahn Y, Liu XF, Nagata S, Lee B, Bera TK, Pastan I. Lee Y, et al. Among authors: pastan i. Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17885-90. doi: 10.1073/pnas.0608344103. Epub 2006 Nov 13. Proc Natl Acad Sci U S A. 2006. PMID: 17101985 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,281 results

Search Page